Abstract Submission Guidelines

Basic Science (AS01)

  • AS01b. Animal Models and Papillomaviruses
  •  AS01c. Immunology
  •  AS01d. Regulation of Gene Expression, Post-transcriptional Modification
  •  AS01e. Transformation and Carcinogenesis
  •  AS01f. Structural Biology
  •  AS01g. Virus – Host Interactions
  •  AS01h. Virus Life Cycle
  •  AS01i. Genomics of HPV-associated Disease
  •  AS01j. Papillomavirus Vaccines: Basic Science Aspects
  •  AS01k. Beta and Gamma Cutaneous HPV Infection, Biology, and Natural History
  • AS01l. Microbiome
  • AS01m. Pre-clinical studies of biomarkers?
  • AS01n. Other basic science topics related to papillomavirus biology and pathogenesis

Clinical Science (AS02)

  • AS02a. Cervical precancers and cancers: Diagnosis, decision making and follow up in the setting of HIC
  •  AS02b.Cervical precancers and cancers: Diagnosis, decision making and follow up in the setting of  LMIC
  •  AS02c. Anal HPV associated precancers and cancers: Diagnosis, decision making and follow up
  •  AS02d. HPV associated anogenital cancers other than cervix (penile, vaginal, vulvar precancers and cancers): Diagnosis, decision making and follow up
  •  AS02e. Clinical evaluations of treatments of cervical, anal, vulvar, vaginal and penilel  pre-cancer and cancer and of other HPV associated diseases
  •  AS02f. HPV associated oral cancers and precancers: Diagnosois, management and treatment
  •  AS02g. Diagnosis and management of HPV disease in special populations (immunosuppressed, PLHIV, gender and non-binary communities, children, history of sexual abuse)
  •  AS02h. Innovation in sample collection for HPV related screening
  •  AS02i. Clinical evaluations of novel biomarkers for diagnosis, management and post treatment follow up for cervical precancers and cancers
  •  AS02j. Clinical evaluations of biomarkers for diagnosis, management and post treatment follow up for anal precancers and cancers
  •  AS02k. Clinical evaluations of biomarkers for diagnosis, management and post treatment follow up for oral precancers and cancers
  •  AS02l. Clinical evaluations of biomarkers for diagnosis, management and post treatment follow up for other HPV associated precancers and cancers (penile, vulvar, vaginal)
  •  AS02m. Emerging therapeutic vaccines and antivirals for HPV associated disease –Clinical Aspects (efficacy and safety)
  •  AS02n. Prophylactic vaccines (clinical trial data, safety and efficacy)
  •  AS02o. Rapid assays for the detection of HPV-Related Disease
  •  AS02p. HPV NAAT screening quality control/assurance guidelines
  •  AS02q. AI technology for diagnosis, management, and decision making in HPV-associated disease
  •  AS02r. Recurrent respiratory papillomatosis (clinical aspects including diagnosis, clinical management)
  •  AS02s. Psyco-social  elements and cultural factors impacting HPV associated testing, diagnosis, management and treatment of women with HPV associated diseases
  • AS02t. Other clinical research topics related to HPV-associated disease

Population Science and Public Health (AS03)

  • AS03a. Primary results for clinical trials in public health and HPV
  • AS03b. HPV epidemiology and natural history at multiple anatomic sites
  • AS03c. Local/regional/country-specific reports of HPV vaccination and screening coverage
  • AS03d. HPV vaccination: Effectiveness and impact
  • AS03e. HPV vaccination: Local/regional/national program reports
  • AS03f. HPV vaccination: Implementation science
  • AS03g. Cervical Screening: Local/regional/national program reports
  • AS03h. Cervical Screening: Implementation science
  • AS03i. Implementation Science related to HPV infection and related disease prevention
  • AS03j. Prevention (primary and secondary) of HPV-related anal cancer
  • AS03k. Prevention (primary and secondary) of HPV-related oropharyngeal cancer
  • AS03l. Recurrent Respiratory Papillomatosis: epidemiology and prevention
  • AS03m. Prevention (primary and secondary) of HPV-related penile, vaginal, vulvar disease
  • AS03n. Health economics and mathematical modelling of HPV and HPV-related conditions
  • AS03o. AI and machine learning in HPV-related population health research
  • AS03p. Behavioral and social science aspects of HPV prevention
  • AS03q. Knowledge, Awareness, and Communications research for HPV prevention
  • AS03r. Population health and HPV prevention for special populations (e.g., transgender and non-binary communities, children, history of sexual abuse, immigrants, refugees)
  • AS03s. Population health and HPV prevention for HIV, transplant, and other immunosuppressed populations
  • AS03t. Other population science topics related to HPV infection and related disease prevention